µå·¯±×ÀÎÆ÷¸ÞÀÎ
µå·¯±×ÀÎÆ÷¿¡ ¿À½Å°ÍÀ» ȯ¿µÇÕ´Ï´Ù.
left1
  ÀǾàÇ°   Á¦Ç°½Äº°   º¹¾àÁöµµ   »óÈ£ÀÛ¿ë   ½ÅÀå¾Ö¾à¿ë·®   º¸Çè½É»ç±âÁØ  
right1
left2
ÀǾàÇ°°Ë»ö line ¾àÈ¿ºÐ·ù line ÀûÀÀÁõ line Á¦Á¶,ÆǸŻç line ¼öÀÔÀǾàÇ° line Èñ±ÍÀǾàÇ° line Ç×Á¤ÀǾàÇ° line ÇÑ¿Ü,¸¶¾à line ¿À³²¿ë¿ì·Á  
right2
Ç×¾ÏÁ¦ (Oncology)
  Ç¥ÀûÄ¡·á Ç×¾ÏÁ¦(Targeted cancer therapy)
  ´ÜŬ·ÐÇ×ü(Monoclonal antibodies)
  Rituximab 500mg
 
°Ë»öµÈ Á¦Ç°¸í (À¯ÅëÁßÀÎ Á¦Ç°) ÃÑ 3°³
´ëÁ¶¾à:¡Ü »ýµ¿¼º½ÃÇè¿Ï·á:¡Ü ºñ±³¿ëÃâ½ÃÇè¿Ï·á:¡Ü
Á¦Ç°¸í ÆÇ¸Å»ç ±¸ºÐ º¸Çè º¸Çè°¡ ´ëü
¸¿Å׶óÁÖ(¸®Åö½Ã¸¿) 50mL(ÁÖ)Çѱ¹·Î½´Àü¹®±Þ¿©897,482 ¿ø ¡Ü
½ÎÀ̽ø¿ÁÖ(¸®Åö½Ã¸¿) 50mL½ÎÀÌÁ¨ÄÚ¸®¾Æ(ÁÖ)Àü¹®ºñ±Þ¿©0 ¿ø 
Æ®·è½Ã¸¶ÁÖ(¸®Åö½Ã¸¿) 50mL(ÁÖ)¼¿Æ®¸®¿ÂÁ¦¾àÀü¹®±Þ¿©809,077 ¿ø ¡Ü
[1]
»èÁ¦.¹Ì»ý»ê Á¦Ç° (À¯ÅëµÇÁö ¾ÊÀº Á¦Ç°) ÃÑ 1°³
Á¦Ç°¸í ÆÇ¸Å»ç ±¸ºÐ »ý»ê¿©ºÎ
¸¿Å׶óÁÖ(¸®Åö½Ã¸¿) (50mL)(ÁÖ)Çѱ¹·Î½´Àü¹® 
[1]
 
ºñÆ®µå·¯±×ÀÎÆ÷